|
|
Antimicrob Agents Chemother. 1993 August; 37(8): 1679–1684. | PMCID: PMC188041 |
Therapy of human hydatid disease with mebendazole and albendazole. A Teggi, M G Lastilla, and F De Rosa Second Chair of Infectious Diseases, Università degli Studi di Roma La Sapienza, Italy. Abstract We report our experience in the treatment with benzoimidazole carbamates (mebendazole and albendazole) of 337 patients affected by hydatid cysts with different localizations. The treated cysts showed degenerative modifications in 50.6% of the cases after mebendazole treatment and in about 80% after albendazole treatment. Relapses after therapy were observed in 30% of the cases; about 95% of the recurring cysts showed good susceptibility to a further cycle of therapy with benzoimidazole carbamates. Side effects observed with either drug were not severe and always reversible, consisting mainly of abdominal pains and increased levels of transaminases in serum. Among the factors that may influence the therapeutic results are the drug employed, the age of the cysts, the age of the patient, and the localization of the cysts and their morphological characteristics. Moreover, it can be hypothesized that each hydatid cyst has an intrinsic sensitivity to benzoimidazole carbamates. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Aceti A, Celestino D, Teggi A, Caferro M, Pennica A, Grilli A, Sebastiani A, De Rosa F. Histamine release test in the diagnosis of human hydatidosis. Clin Exp Allergy. 1989 May;19(3):335–339. [PubMed]
- Bekhti A, Schaaps JP, Capron M, Dessaint JP, Santoro F, Capron A. Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J. 1977 Oct 22;2(6094):1047–1051. [PubMed]
- Bezzi M, Teggi A, De Rosa F, Capozzi A, Tucci G, Bonifacino A, Angelini L. Abdominal hydatid disease: US findings during medical treatment. Radiology. 1987 Jan;162(1 Pt 1):91–95. [PubMed]
- Campbell WC, Blair LS. Treatment of the cystic stage of Taenia crassiceps and Echinococcus multilocularis in laboratory animals. J Parasitol. 1974 Dec;60(6):1053–1054. [PubMed]
- Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ. 1986;64(3):383–388. [PubMed]
- De Rosa F, Teggi A. First experience in the treatment of human hydatid disease with mebendazole. Drugs Exp Clin Res. 1985;11(12):875–878. [PubMed]
- Gemmell MA, Parmeter SN, Sutton RJ, Khan N. Effect of mebendazole against Echinococcus granulosus and Taenia hydatigena cysts in naturally infected sheep and relevance to larval tapeworm infections in man. Z Parasitenkd. 1981;64(2):135–147. [PubMed]
- Heath DD, Chevis RA. Letter: Mebendazole and hydatid cysts. Lancet. 1974 Jul 27;2(7874):218–219. [PubMed]
- Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg. 1989 Jan–Feb;83(1):97–102. [PubMed]
- Kammerer WS, Judge DM. Chemotherapy of hydatid disease (Echinococcus granulosus) in mice with mebendazole and bithionol. Am J Trop Med Hyg. 1976 Sep;25(5):714–717. [PubMed]
- Kammerer WS, Schantz PM. Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. Am J Trop Med Hyg. 1984 Jan;33(1):132–137. [PubMed]
- Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990 Apr;6(4):112–115. [PubMed]
- Luder PJ, Robotti G, Meister FP, Bircher J. High oral doses of mebendazole interfere with growth of larval Echinococcus multilocularis lesions. J Hepatol. 1985;1(4):369–377. [PubMed]
- Morris DL, Dykes PW, Dickson B, Marriner SE, Bogan JA, Burrows FG. Albendazole in hydatid disease. Br Med J (Clin Res Ed). 1983 Jan 8;286(6359):103–104. [PubMed]
- Morris DL, Dykes PW, Marriner S, Bogan J, Burrows F, Skeene-Smith H, Clarkson MJ. Albendazole--objective evidence of response in human hydatid disease. JAMA. 1985 Apr 12;253(14):2053–2057. [PubMed]
- Müller E, Akovbiantz A, Ammann RW, Bircher J, Eckert J, Wissler K, Witassek F, Wüthrich B. Treatment of human echinococcosis with mebendazole. Preliminary observations in 28 patients. Hepatogastroenterology. 1982 Dec;29(6):236–239. [PubMed]
- Ramalingam S, Sinniah B, Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am J Trop Med Hyg. 1983 Sep;32(5):984–989. [PubMed]
- Saimot AG, Meulemans A, Cremieux AC, Giovanangeli MD, Hay JM, Delaitre B, Coulaud JP. Albendazole as a potential treatment for human hydatidosis. Lancet. 1983 Sep 17;2(8351):652–656. [PubMed]
- Schantz PM, Van den Bossche H, Eckert J. Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd. 1982;67(1):5–26. [PubMed]
- Singcharoen T, Mahanonda N, Powell LW, Baddeley H. Sonographic changes of hydatid cyst of the liver after treatment with mebendazole and albendazole. Br J Radiol. 1985 Sep;58(693):905–907. [PubMed]
- Todorov T, Vutova K, Mechkov G, Petkov D, Nedelkov G, Tonchev Z. Evaluation of response to chemotherapy of human cystic echinococcosis. Br J Radiol. 1990 Jul;63(751):523–531. [PubMed]
- Verheyen A. Echinococcus granulosus: the influence of mebendazole therapy on the ultrastructural morphology of the germinal layer of hydatid cysts in humans and mice. Z Parasitenkd. 1982;67(1):55–65. [PubMed]
|
This article has been